Colorado-based Enveda, which uses AI to discover new drugs in the natural world, raised a $311M Series E at a $2B valuation, double its valuation a year ago (Marina Temkin/TechCrunch)

Enveda raised $311 million at a $2 billion valuation to advance AI-driven drug discovery. Anthropic’s Claude agents identified a novel CRISPR-like enzyme system in bacteriophage DNA, while Google launched Gemini 3.8 Flash TTS models supporting over 100 languages. Additionally, YouTube introduced AI-powered storytelling tools and custom homepage feeds to compete for creator exclusivity.